Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers
about
sameAs
Cdc123 and checkpoint forkhead associated with RING proteins control the cell cycle by controlling eIF2gamma abundanceChfr is linked to tumour metastasis through the downregulation of HDAC1Loss of CHFR in human mammary epithelial cells causes genomic instability by disrupting the mitotic spindle assembly checkpointEpigenetic inactivation of CHFR in human tumorsChfr acts with the p38 stress kinases to block entry to mitosis in mammalian cellsDNA demethylation caused by 5-Aza-2'-deoxycytidine induces mitotic alterations and aneuploidyYeast Chfr homologs retard cell cycle at G1 and G2/M via Ubc4 and Ubc13/Mms2-dependent ubiquitination.DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an updateConcomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokersChfr is required for tumor suppression and Aurora A regulationSafeguarding entry into mitosis: the antephase checkpoint.Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population.Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis.RNF8-dependent histone ubiquitination during DNA damage response and spermatogenesisChfr and RNF8 synergistically regulate ATM activation.Regulation of the DNA damage response by ubiquitin conjugation.The auto-ubiquitylation of E3 ubiquitin-protein ligase Chfr at G2 phase is required for accumulation of polo-like kinase 1 and mitotic entry in mammalian cells.Gene-promoter hypermethylation as a biomarker in lung cancer.Throwing new light on lung cancer pathogenesis: updates on three recent topics.Applying whole-genome studies of epigenetic regulation to study human disease.CHFR is important for the first wave of ubiquitination at DNA damage sitesPromoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epitheliaCHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC.CHFR: A Novel Mitotic Checkpoint Protein and Regulator of Tumorigenesis.Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancer.Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice.Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine.CHFR: a key checkpoint component implicated in a wide range of cancers.Epigenetic Determinants of Cancer.Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype.SNM1A acts downstream of ATM to promote the G1 cell cycle checkpointAssociation between CHFR gene hypermethylation and gastric cancer risk: a meta-analysisSustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR.Epigenetic silencing of checkpoint with fork-head associated and ring finger gene expression in esophageal cancer.Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach.The diagnostic and prognostic value of CHFR hypermethylation in colorectal cancer, a meta-analysis and literature review.Clinicopathological significance of CHFR methylation in non-small cell lung cancer: a systematic review and meta-analysis.TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas.
P2860
Q24301653-6C779FBB-6327-49F6-829D-C5203008B872Q24324032-7D28FBB6-7C45-4E63-B7A6-F8FD265EB282Q24652321-3EE72B75-5FEE-4F0D-A15F-CFAB673B7093Q24670147-2C480489-57EE-466F-9E8D-10A0AC5465D8Q24676923-2B01432D-8A8E-4566-9322-9952981CC589Q27339980-CA698244-9004-4B91-A410-F23D1BBAC065Q27936398-5E0CD86D-69D4-4F6F-B38D-62233FC073CCQ28386334-E818E234-C286-4E2F-BC61-DDEA5D0E4549Q28389551-1D01195A-441F-4421-B766-7DCFC0728709Q28510913-1C0E4065-88E1-4325-ACE3-F346DD4FE120Q33558235-294B007A-3DDD-4517-9237-D7F1E94DB8BEQ33887581-25E2D733-6FD6-4691-A0A1-6CEE76452862Q34091569-1F0170F6-A816-454A-8909-FA79F8BB8721Q34152941-BC0446D1-68FB-4E5B-BBB5-102952AEA1D9Q34829400-0F9E6BAA-08F5-4B13-9FF7-C1C86431BE96Q35089499-AFA10B01-709F-4871-949C-E8B8FFF2A441Q35161624-3010CF45-E525-471A-80D4-FAADEDB962B3Q35182916-56F65062-DA82-4F46-9AC8-055DD91A2BCAQ35877182-4108C674-292E-44CA-8F14-7B11373AD6E8Q36050719-41A1A592-4D09-4809-8C7A-CAE7492A970EQ36485572-DDA4DC98-3EE7-4635-8591-34DBF9B8984EQ36580923-D7649F27-338D-41E4-969D-7E33F4AB5699Q36694133-7E336D25-0AF0-4225-9758-0BC54EA86272Q36698563-C288AF69-6F3D-40DF-B78A-B572D0A0E282Q36831407-91C30DAE-4E6A-495B-8E79-7A04D58AE442Q37203411-99FC2A9E-4BAF-40F9-901E-3C495E6BCCB6Q37328459-6A3613E7-085C-424C-9DEE-9C0D5D165028Q37705684-6190EAF4-6854-4E74-9363-AACEA7BB98E3Q37967195-DC023498-D32D-4538-96D0-0F1F11374185Q38837858-B03C9A72-CCCD-4B99-A702-03F313E56AB6Q39485439-7F366359-512E-4291-B6FE-D2AE1E250EDBQ40448024-4B7C6F94-8F25-42A0-83DE-96E54715F4BFQ41660937-8AA9FC9D-11C9-4422-969F-ABAE7B473B50Q41947888-E4E0DEA1-D503-4789-918F-014BB2DF1D2DQ42289696-704DCBDA-153A-4F40-8015-292D91FC7478Q42801200-B41BC93C-E602-4695-8FD1-87EE9E101997Q44522889-84327303-F783-4AEE-A13D-0022EB902917Q47134227-F92927FC-DA38-4A65-8CD7-EC864306425DQ47193635-18C42D13-C026-4119-8E70-B6188FE5404EQ48247270-E92D89E4-4CEB-4135-9E63-C86D6CEAA820
P2860
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers
description
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im April 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 4 April 2002)
@en
vedecký článok (publikovaný 2002/04/04)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/04/04)
@nl
наукова стаття, опублікована у квітні 2002
@uk
مقالة علمية (نشرت في 4-4-2002)
@ar
name
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers
@ast
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers
@en
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers
@nl
type
label
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers
@ast
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers
@en
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers
@nl
prefLabel
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers
@ast
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers
@en
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers
@nl
P2093
P2860
P50
P356
P1433
P1476
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers
@en
P2093
Hirotaka Osada
Kotaro Mizuno
Tetsuya Mitsudomi
Yoshio Tatematsu
Yoshitaka Fujii
P2860
P2888
P304
P356
10.1038/SJ.ONC.1205402
P407
P577
2002-04-01T00:00:00Z
P5875
P6179
1039745972